Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anti-N-Methyl-D-Aspartate Receptor Encephalitis × Rituximab × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 77 Lymphoma 48 Lymphoma, Non-Hodgkin 47 Lymphoma, Mantle-Cell 47 Lymphoma, Follicular 47 Lymphoma, B-Cell, Marginal Zone 41 Leukemia, Lymphocytic, Chronic, B-Cell 40 Lymphoma, B-Cell 28 Burkitt Lymphoma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Waldenstrom Macroglobulinemia 17 Recurrence 17 Neoplasms 12 Leukemia 12 Leukemia, Hairy Cell 8 Hodgkin Disease 8 Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm, Residual 4 Lymphoproliferative Disorders 4 Hematologic Diseases 4 Dendritic Cell Sarcoma, Interdigitating 4 Lymphoma, AIDS-Related 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Biphenotypic, Acute 3 Blast Crisis 3

Interventions

ofatumumab 1 daratumumab 1 Salpingo-oophorectomy 1 Magnetic Resonance Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡